Marian Nakada is VP Venture Investments, and in this role, she identifies promising life science companies to invest in that are on strategy for Johnson & Johnson Innovative Medicine and that are based in East North America. She has over 30 years of experience in the pharmaceutical industry, starting her career at the laboratory bench at Centocor and moving to a research leadership role before Centocor’s acquisition by Johnson & Johnson. She later transitioned to a business development role and then joined JJDC in 2013. Marian has a A.B. in Biology from Harvard and a Ph.D. in Pharmacology from the University of Pennsylvania. She has authored 62 peer reviewed publications and 14 book chapters and is a past reviewer for the NIH Pharmacology Study Section. She is currently on the Boards of ONL Therapeutics, Navitor Therapeutics, and PAQ Therapeutics